Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 7:47 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 494 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fish OIl Clear all

Conditions: Age-related Macular Degeneration, Cataract
Interventions: Lutein/zeaxanthin, DHA/EPA, Lutein/zeaxanthin and DHA/EPA; Dietary Supplement · Drug
Lead sponsor: National Eye Institute (NEI); NIH
Eligibility: 50 Years to 85 Years
Enrollment: 4,203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 91
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Beverly Hills, California + 72 more

Conditions: Stress, Physiological
Interventions: The Optimum Omega-3 Fatty Acid Feeding Study; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 40 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Dry Eye Syndromes, Age-Related Macular Degeneration, Omega 3 Index
Interventions: OmegaBoost, Nature Made (soft gel), Nature Made (gummy); Dietary Supplement
Lead sponsor: Western University of Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Pomona, California

Conditions: Breast Cancer
Interventions: Lovaza 4gm oral, Raloxifene 60 Mg Oral Tablet, Raloxifene 30 Mg Oral Tablet, Lovaza 4gm & Raloxifene 30mg; Dietary Supplement · Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 35 Years to 70 Years · Female only
Enrollment: 266 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Chronic Myeloid Leukemia, Chronic Phase
Interventions: Eicosapentaenoic Acid, Tyrosine kinase inhibitor; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Cholestasis
Interventions: Omegaven; Drug
Lead sponsor: Carle Foundation Hospital; Other
Eligibility: 14 Days to 4 Months
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Myofacial Pain
Interventions: MyoRx Cream (6% Omega 3 Fatty Acid), Placebo cream, no Omega 3 fatty acid; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Hypercholesterolaemia
Interventions: Alirocumab SAR236553 (REGN727), Rosuvastatin, Atorvastatin, Simvastatin, Pravastatin, Lovastatin, Fluvastatin, Ezetimibe, Cholestyramine, Nicotinic acid, Fenofibrate, Omega-3 fatty acids, Placebo; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 8 Years to 17 Years
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 5
States / cities: Boca Raton, Florida • St Louis, Missouri • Charlotte, North Carolina + 2 more

Conditions: Postoperative Delirium
Interventions: Omega-3 Ethyl Esters 4 g, Omega-3 Ethyl Esters 2 g; Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 65 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Chronic Kidney Disease, Cardiovascular Disease
Interventions: Fish Oil and Bicarbonate, Fish Oil and Bicarbonate Placebo, Fish Oil Placebo and Bicarbonate, Fish Oil Placebo and Bicarbonate Placebo; Dietary Supplement
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 60 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Multiple Myeloma, Smoldering, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance
Interventions: Omega-3, Curcumin, Probiotic, Whole food, plant-based diet (WFPBD); Dietary Supplement · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Retinitis Pigmentosa, X-linked Genetic Diseases
Interventions: docosahexaenoic acid OR corn/soy oil placebo; Drug
Lead sponsor: Retina Foundation of the Southwest; Other
Eligibility: 7 Years to 32 Years · Male only
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Depression, Depressive Symptoms, Mood
Interventions: vitamin D3, omega-3 fatty acids (fish oil), Fish oil placebo, Vitamin D placebo; Dietary Supplement · Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 50 Years and older
Enrollment: 18,353 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Total Parenteral Nutrition-Induced Cholestasis
Interventions: Omegaven; Drug
Lead sponsor: University of Nebraska; Other
Eligibility: Up to 18 Years
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Ocular Surface Disease
Interventions: Fishoil supplement, Olive Oil; Dietary Supplement
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hyperlipidemia
Interventions: FishOil, CBE75, CBE150, placebo; Dietary Supplement
Lead sponsor: MetaProteomics LLC; Industry
Eligibility: 18 Years to 72 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Gig Harbor, Washington

Conditions: Autistic Disorder
Interventions: B12, Placebo, folate, B complex, vitamin C, cod liver oil, Mineral complex, carnitine; Dietary Supplement
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 3 Years to 7 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Breast Cancer
Interventions: omega 3 fatty acids; Dietary Supplement
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 2
States / cities: Duarte, California • Columbus, Ohio

Conditions: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: insulin glargine (HOE901), omega-3 polyunsaturated fatty acids (PUFA), placebo, reusable pen device for insulin injection; Drug · Device
Lead sponsor: Sanofi; Industry
Eligibility: 50 Years and older
Enrollment: 12,537 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Metabolic Syndrome
Interventions: EPA, DHA, sunflower oil; Dietary Supplement
Lead sponsor: Tufts University; Other
Eligibility: 50 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Physiological Effects of Fish Oil
Interventions: Fish OIl; Dietary Supplement
Lead sponsor: University of Michigan; Other
Eligibility: 25 Years to 75 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Retinitis Pigmentosa
Interventions: Vitamin A, Docosahexaenoic acid, Control fatty acid; Dietary Supplement
Lead sponsor: Carol Weigel DiFranco; NIH
Eligibility: 18 Years to 55 Years
Enrollment: 221 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1996 – 2002
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cancer Patients Receiving Chemotherapy or Chemoradiotherapy
Interventions: Daily intake for 10 weeks (+/- 2 weeks); Dietary Supplement
Lead sponsor: Texas A&M University; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: College Station, Texas

Conditions: IgA Glomerulonephritis
Interventions: omega-3 fatty acids, prednisone, Placebo; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: Up to 40 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2007
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

Age-Related Eye Disease Study 2 (AREDS2)

The Optimum Omega-3 (003) Diet Study

Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals

Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention

Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Omegaven® as Parenteral Nutrition

Topical Application of MyoRx (Omega 3 Fatty Acids Containing) Cream

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery

Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

DHA and X-Linked Retinitis Pigmentosa

VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL

Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children

Omega 3 Supplementation and Ocular Surface Disease in Glaucoma

Effect of Citrus Bioflavonoids/Vitamin E in Conjunction With Fish Oil Supplementation

Treating Oxidative Stress and the Metabolic Pathology of Autism

Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention

The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)

Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and Lipids

Effects of Fish Oil on the Colon Mucosa

Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A

Nutrition Intervention During Chemotherapy

Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy